Collaboration project with Oncosyne
We are happy to announce that the rOoC platform will be used for precision cancer therapy by the Norwegian Startup Oncosyne:
Early this year, Oncosyne received a prestigious „Innovasjonsprosjekt i næringslivet (IPN)“ grant worth 16 MNOK from the Research Council of Norway with the aim to develop a pancreatic cancer on-chip model on the rOoC platform. We are super happy to contribute to this interesting and important topic with our knowledge on MPS. Maybe we can together help to defeat one of the most severe cancer types.
